chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID-19 treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 from 22Aug2023 till 26Aug2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300292723 same patient different drug/events;
Vertigo; Numb hands and arms; Was sore all over; Throat closed; Trouble swallowing; Trouble breathing; Itchy feeling all over body; Bad headaches; Tingly hands and arms; Fatigue feeling/tired very easily; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0176) via an unspecified route of administration in the arm right on 02May2021 at 16:30(at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 18:00, the patient had bad headaches within a couple of hours worst in his life for about 4 days, vertigo for 6-7 days, itchy feeling all over body, numb and tingly hands and arms. The patient was sore all over and fatigue feeling for at least 6 days. Throat closed had trouble swallowing and had trouble breathing got tired very easily. Patient was in so much pain; as patient wanted to pull his hair out. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vertigo, numb and tingly hands and arms, sore all over, throat closed, trouble swallowing, trouble breathing, itchy feeling all over body, bad headaches and fatigue feeling/tired very easily were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
21 year old otherwise healthy and no history of previous seizures, that presented with seizure/status epilepticus on January 24th, 2022, 10 days after covid vaccine booster. Presumed autoimmune encephalitis after extensive work up,  leading to status epilepticus and extremely difficult to control seizures with ongoing breakthrough events. Patient with ongoing hospitalization, mostly in ICU, and suffering from debility along with likely permanent cognitive impairment.
Pt recvd vax & 2 days later devel erythema nodosum; the adverse exp was described on follow-up as welts, rash, itching, swelling & retaining water;
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021 at 1:27 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Feb-2021 at 1:27 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  The age of patient was provided as 78.05.  On 17-Feb-2021, Excursion time was 09 AM, temperature was 22, total doses given for the day was not reported, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 11-Feb-2021, vial was moved to clinic on 17-Feb-2021. 5 vials were sent to clinic. Vaccine BUD date was 13-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34- or 35-degree F.  Treatment medications were not reported.
Woke up with pain under left armpit and felt a lump. Smallpox vaccination site was red and swollen with other lesions present.
Severe swelling, redness and pain in right arm pit (Lymph Noles) and right arm; Seen by doctor and had to get a shot for inflammation, and  2 prescriptions. Around 11:30 pm  on 4/27/21, had nausea, diarreah, chills/shaking uncontrollably and headache.
Period problems; Period problems; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (Period problems) and MENSTRUATION DELAYED (Period problems) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION IRREGULAR (Period problems) and MENSTRUATION DELAYED (Period problems). At the time of the report, MENSTRUATION IRREGULAR (Period problems) and MENSTRUATION DELAYED (Period problems) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient's LMP was 06-Jun-2021 and got period on 26-Sep-2021.  No concomitant medication was taken by patient regularly. No treatment medication was reported by reporter.   This case was linked to MOD-2021-429683 (Patient Link).
not feeling up to par; with flu like symptoms that are not nearly as severe as after the 2nd shot; a little tired; feeling a little bit the the usual achy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling up to par), INFLUENZA LIKE ILLNESS (with flu like symptoms that are not nearly as severe as after the 2nd shot), MYALGIA (feeling a little bit the the usual achy) and FATIGUE (a little tired) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced MYALGIA (feeling a little bit the the usual achy). On an unknown date, the patient experienced FEELING ABNORMAL (not feeling up to par), INFLUENZA LIKE ILLNESS (with flu like symptoms that are not nearly as severe as after the 2nd shot) and FATIGUE (a little tired). At the time of the report, FEELING ABNORMAL (not feeling up to par), INFLUENZA LIKE ILLNESS (with flu like symptoms that are not nearly as severe as after the 2nd shot), MYALGIA (feeling a little bit the the usual achy) and FATIGUE (a little tired) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2021-089432 (Patient Link).
Patient experienced double vision, nausea, weakness, and felt disoriented within 10 minutes of getting the vaccine and this lasted for 4 hours after.
Pt complained of feeling sore after shot. Thursday at 21:00, noticed severe redness, swelling and hardness on the top, inner, outer thigh. Redness on top and outer, only. Parent gave child Motrin and it helped child relax and sleep. Child didn't want to be touched on the leg at all. Some decrease in redness and swelling this AM.
an improperly stored dose of PEDVAX was administered to the patient on an unknown date; No adverse effects; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot # N024570, expiration date: 01-MAY-2020 (strength, dose, schedule and route of administration were unknown) for prophylaxis (product storage error). The vaccine underwent temperature excursion below 36-degree Fahrenheit: 32.1 Fahrenheit for a duration of 8 hours. There was no previous temperature excursion. There was an involvement of data logger. No product quality complaints (PQC) were involved.
Two days after vaccine - I break out in a rash on my arms, legs, back, neck.  It is a allergic reaction rash.  It has lasted four days and still going.  Very itchy and burning.  Red welts.  Have been taking Bendryl and Zytrtec
Edema on the lower extremities; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 01Jun2021 (Lot number: EW0178, Expiration Date: 31Aug2021) at the age of 68 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OEDEMA PERIPHERAL (non-serious) with onset Jun2021, outcome "unknown", described as "Edema on the lower extremities".  Additional information: Clinical course: It was reported that a patient was given a dose of the PFIZER-BIONTECH COVID-19 VACCINE on 01Jun2021 and had developed edema on the lower extremities. Reporter was not positive that this AE was brought by the vaccine but still wanted to check and wants to know if this has been reported as a side effect of the vaccine. The reporter intern would like to know if anyone else is experiencing this. If any more people are reporting this. If it's common. He doesn't think it's related to the vaccine. He would like to verify to make sure it's not something due to the Pfizer vaccine. Reporter stated today is the first time he has contacted Pfizer. He believes some of the pharmacy staff have contacted Pfizer before.  No follow-up attempts are possible. No further information is expected.
Pt exp numbness in leg up to groin level 9 days p/recvd Typhoid vax; pt also exp difficulty walking w/poor balance & a demyelinating event; Pt slowly began to improve until JUN88 when the improvement stopped; pt continues to exp sxs;
2 hours, post vax, child became quiet, slight temperature, became unresponsive and temperature went up to 104F. Mom took infant to ER and child was hospitalized for 2 weeks. Now child is mentally and developmentally delayed. Dx'd child as autistic and delayed developmentally.
Rash, pink maculopapular rash 3 ruptured vesicles, mild itch, rash began 11/24/04.
Patient desired MMR- gave Proquad (pediatric dose MMR-Varicella)) instead of MMR No adverse effects
felt soreness in her arm/shoulder and nothing else; felt soreness in her arm/shoulder and nothing else; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (lot number and expiry date: unknown) as dose 2, single, for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for Covid-19 immunisation. On unspecified date, the patient felt soreness in her arm/shoulder and nothing else. The clinical course was reported as follows: Everything went well for the first COVID-19 vaccine, but with the second vaccine, she was not sure if she received it. She felt soreness in her arm and nothing else. She was not very satisfied with the center she received the vaccine at. The person administering the vaccine was very cold, almost hostile. She was concerned if she actually got it. She stated that she has documents on what the responses should be, and she did not receive response as far as the vaccine goes except for her shoulder being sore. Outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information expected.
Pt was to receive dtap, mistakenly received tdap.  "If Tdap is administered inadvertently as the fourth or the fifth dose in the tetanus-diphtheria-pertussis vaccination series, the Tdap dose should be counted as valid and does not need to be repeated; the child who received Tdap as a fourth dose should complete the pediatric DTaP schedule. The adolescent Tdap dose should be administered as recommended when this child is aged 11?12 years.""
Patient admitted as inpatient on 1/12/22 due to atrial fibrillation with RVR. Patient was tested for COVID-19 and was positive on 1/10/22.
Excrutiating joint pain; experience itching that waxes and wanes; pain was enought to wake her up at night; shingles/she broke out in the shingles rash; mild rash; severe nerve pain; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included muscle injury. Previously administered products included Zostavax (received 5 years ago). Concurrent medical conditions included pain (still experiencing the pain and still thought it was an injury).   On 2nd October 2019, the patient received Shingrix. On 3rd October 2019, 1 days after receiving Shingrix, the patient experienced shingles and rash. In October 2019, the patient experienced nerve pain. On an unknown date, the patient experienced joint pain, pruritus and difficulty sleeping. The patient was treated with antivirals nos. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the joint pain was not recovered/not resolved and the outcome of the nerve pain, pruritus, rash and difficulty sleeping were unknown.   It was unknown if the reporter considered the shingles, nerve pain, pruritus, rash and difficulty sleeping to be related to Shingrix. The reporter considered the joint pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and came down with the shingles the next day.   The patient did not believe that the Shingrix caused the shingles.  She believes she was coming down with shingles a few days before having the vaccine.   She also experienced excrutiating joint pain after getting the Shingrix vaccine. She still has it. The patient visited the emergency room 2 days prior to getting the vaccine. The next day she broke out in the shingles rash and she realized that she was already coming down with shingles when she got the vaccine. She thinks the vaccine exacerbated the case of shingles because she had a very severe case with the rash going across from her naval to her spine and down from the T4 vertebrae to the iliac crest. She was treated with a 7 days course of antiviral and the rash cleared up some. While taking the antiviral she did not experience pain, but once she completed the antiviral course she did develop the severe nerve pain. The rash did not fully clear up and after several weeks she took another 7 day course of antiviral. The 2nd course of antiviral cleared up the rash more and stopped most of the pain. She did not have pain from the shingles, but she experience itching that waxes and wanes and she still has a mild rash. In addition to shingles she also developed severe joint pain after getting the vaccine. The joint pain was enough to wake her up at night. She has never experienced joint pain before. The joint pain was subsiding, but still present. She thinks the joint pain was related to Shingrix, but not the case of shingles she experienced. She was currently in very good physical condition. She did not generally have any joint pain and exercises regularly.
Flu vaccine was voluntarily given by my employer at my work site on Friday, November 16, 2007.  On Saturday, November 17, 2007 I awoke to a large red itchy swollen area at the site of the injection (upper left arm) about 7" in diameter.  My neck and chest were itchy as well.  I treated my symptoms by applying a topical allergy cream.  Sunday, November 18, 2007 I am still treating symptoms.
Constant Nausea, Headaches including Migraine, Bladder pain syndrome/interstitial cystitis
8  days post-vaccination, pt developed a raised, bumpy erythematous rash at the site of the injection. ~1 in. Not itchy. Not tender. Within 24 hours, developed central clearing with underlying induration. ~1.5 inches. Not itchy. Not tender. Rash almost completely gone within 48 hours of symptom onset. NO OTHER ASSOCIATED SX.
Bad headache; left shoulder pain; left neck pain, stiffness; pain just above kidneys up to shoulder blade on left side
Post Covid boost  vaccine (3rd dose) with persistent strong and heavy  Skin rash, high blood pressure, headache.
Soreness in his lower extremities; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 28Apr2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced soreness in his lower extremities on 29Apr2021. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
discomfort worsened; Discomfort in the arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Discomfort in the arm) and CONDITION AGGRAVATED (discomfort worsened) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 immunization.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced LIMB DISCOMFORT (Discomfort in the arm). On 17-Feb-2021, the patient experienced CONDITION AGGRAVATED (discomfort worsened). At the time of the report, LIMB DISCOMFORT (Discomfort in the arm) and CONDITION AGGRAVATED (discomfort worsened) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment information was provided.  The patient reported seems to be a rotator cuff issue.
had intense muscle aches in the back of the area as well as in the left inner ear, left jawline and left wrist but intensity was less in the last 3 areas
Pt. became pale and lips slightly cyanotic, pupils dilated, loss of consciousness and mild seizing of body for about 10 seconds.
Shingrix dose in question: Jan 1st 2019/ Shingrix confirmed dose: 4/7/2021; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 91-year-old male patient who received Herpes zoster (Shingrix) (batch number 299BM, expiry date 10th October 2022) for prophylaxis.   Previously administered products included Shingrix (first dose received on 1st January 2019).   On 7th April 2021, the patient received the 2nd dose of Shingrix. On 7th April 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional details were reported as follows: The pharmacy student was looking for information about Shingrix third dose because the patient may had received 2 doses of Shingrix but they were not 100 percent  sure and they were planning to give him a potentially Shingrix third dose. The patient's shingrix was 1st dose on 1st January 2019 (dose in question). There were no records about this shot. No lot number was available. The patient received a dose on 7th April 2021, which led to lengthening of vaccination schedule. At the moment of the call, the pharmacy student confirmed only one Shingrix dose given to this patient. The reporter consented to follow up.
Developed Ulcerative Colitis after ANTHRAX 1-4, sxs started 2 years after #4, diagnosis made 1 year after # 4. Diagnosed with narcolepsy in 2008, but had fatigue prior. Symptoms : Diarrhea, Abdominal pain, Day-time somulence, Fatigue, Malaise > 60 days, Weight loss, unexpected. Diagnoses: Ulcerative colitis, narcolepsy
Restricted breathing, light-headed, difficulty drawing a deep breath, minor chest pain and feeling weight on chest when inhaling.  Increase in mucus production with difficulty clearing plugs.
I had numbness and tingling, dizziness, and extreme fatigue for 5 weeks post injection.  these are all Multiple Sclerosis symptoms that I battle with but not all at once and not in extremis.